Amyloid immunotherapy for early Alzheimer's: Promising but fraught with challenges

Amyloid immunotherapy for early Alzheimer's: Promising but fraught with challenges
Researchers highlighted the complexities of using amyloid immunotherapy for early Alzheimer's disease, discussing its clinical benefits, challenges, and broader...
In a recent perspective piece published in the Alzheimer's Association's journal Alzheimer's & Dementia, researchers from the United Kingdom and the Netherlands... Read More



Related Stories

See All